...
首页> 外文期刊>Phlebology >The clinical significance of below-knee great saphenous vein reflux following endovenous laser ablation of above-knee great saphenous vein.
【24h】

The clinical significance of below-knee great saphenous vein reflux following endovenous laser ablation of above-knee great saphenous vein.

机译:膝上大隐静脉静脉激光消融后膝下大隐静脉反流的临床意义。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIMS: The standard technique for endovenous laser ablation (EVLA) for varicose veins due to great saphenous vein (GSV) reflux involves obliteration of the above-knee (AK) GSV. This study assesses the significance of persistent below-knee (BK) GSV reflux following such therapy. METHODS: Sixty-nine limbs (64 patients) with varicosities and GSV reflux underwent AK-EVLA. Post treatment, GSV reflux (ultrasound: six, 12 weeks) and Aberdeen varicose vein severity scores (AVVSS, 12 weeks) were assessed, and residual varicosities treated with foam sclerotherapy (six weeks). RESULTS: The untreated BK-GSV remained patent in all limbs. Ultrasound showed normal antegrade flow in 34/69 (49%, Group A), flash reflux<1 s in 7/69 (10%, Group B) and >1 s reflux in 28/69 (41%, Group C). Although AVVSS improved in all groups (P<0.001): A: 14.6 (8.4-19.3) versus 2.8 (0.5-4.4), B: 13.9 (7.5-20.1) versus 3.7 (2.1-6.8), C: 15.1 (8.9-22.5) versus 8.1 (5.3-12.6) the improvement was less in Group C (P<0.001 versus A and B) and was associated with a greater requirement (A: 4/34 [12%]; B: 1/7 [14%]; C: 25/28 [89%]) for sclerotherapy (persisting varicosities) (P<0.001). CONCLUSION: Although AK-GSV EVLA improves symptoms regardless of persisting BK reflux, the latter appears responsible for residual symptoms and a greater need for sclerotherapy for residual varicosities.
机译:目的:由于大隐静脉(GSV)回流导致的静脉曲张静脉激光消融(EVLA)的标准技术包括消除膝上(AK)GSV。这项研究评估了这种疗法后持续性膝下(BK)GSV反流的重要性。方法:对有静脉曲张和GSV反流的69例肢体(64例患者)行AK-EVLA检查。治疗后,评估GSV反流(超声:6、12周)和阿伯丁静脉曲张严重程度评分(AVVSS,12周),并用泡沫硬化疗法治疗残余静脉曲张(6周)。结果:未经治疗的BK-GSV在所有肢体中均保持专利。超声显示34/69(A组为49%,A组)正常顺行血流,7/69(B组为10%,B组)为<1 s,28/69(C组为41%)> 1s的快速回流。尽管所有组的AVVSS都有改善(P <0.001):A:14.6(8.4-19.3)对2.8(0.5-4.4),B:13.9(7.5-20.1)对3.7(2.1-6.8),C:15.1(8.9- 22.5)与8.1(5.3-12.6)相比,C组的改善较少(P <0.001,而A和B),并且与更高的需求量相关(A:4/34 [12%]; B:1/7 [14 %]; C:25/28 [89%]用于硬化疗法(持续静脉曲张)(P <0.001)。结论:尽管AK-GSV EVLA改善了症状,无论BK持续反流如何,后者似乎是残余症状的原因,并且对于残余静脉曲张的硬化治疗需求更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号